Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Prosenso ApS
APS
Active
CVR 44510014
Kronprinsessegade 6, st.
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2023
— employees
www.prosenso.com
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 392K
EBITDA margin
20.9%
Equity ratio
1.6%
Financial strength
Net profit 2024
DKK 1K
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2024
Key figures
Annual report 2024
Revenue
DKK 392K
—
EBITDA
DKK 82K
—
Net profit
DKK 1K
—
Total assets
DKK 5M
—
Equity
DKK 81K
—
Employees
—
—
Company information
Legal name
Prosenso ApS
CVR number
44510014
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
18. december 2023
Share capital
DKK 40.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør eller af den samlede direktion i forening.
Company purpose
Selskabets formål er at drive virksomhed med handel, service, produktion og dermed forbundne aktiviteter.
Contact
Address
Kronprinsessegade 6, st.
Phone
+4550223300
Email
mail@prosenso.com
Website
www.prosenso.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
DKK thousands
Item
2024
Revenue
392
Staff expenses
-310
EBITDA
82
Depreciation & amort.
-30
EBIT
52
Net financials
-64
Profit before tax
-12
Tax
-13
Net profit
1
Balance sheet
DKK thousands
Item
2024
Total assets
4.971
Equity
81
Long-term debt
0
Short-term debt
4.890
Total debt
4.890
Financial ratios
5-year trend
EBITDA margin
20.9%
This company
15.8%
Market median
+32% vs market
2024
2024
Equity ratio
1.6%
This company
38.2%
Market median
-96% vs market
2024
2024
Return on equity
1.6%
This company
18.4%
Market median
-91% vs market
2024
2024
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
2024
2024
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
2024
2024
Debt / equity
60.17×
This company
0.62×
Market median
-9605% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2023-12-18 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
MO
Michael Ove Kastrupsen
Management
Management
2023
—
—
NK
Niels Kristian Bitsch Kastrupsen
Chief Executive Officer
Chief Executive Officer
2024
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Eastwest Nordic ApS
Company
100.0%
100.0%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Gloves RA Advisory ApS
EWC P/S
Eastwest Nordic ApS
Prosenso ApS
(this company)
Board network connections
Board members of Prosenso ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Michael Ove Kastrupsen
Management
0 companies
Niels Kristian Bitsch Kastrupsen
Chief Executive Officer
0 companies